2010
DOI: 10.1002/jps.22001
|View full text |Cite
|
Sign up to set email alerts
|

Impact of membrane properties on uptake and transcytosis of colloidal nanocarriers across an epithelial cell barrier model

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
16
0

Year Published

2011
2011
2021
2021

Publication Types

Select...
5
3

Relationship

1
7

Authors

Journals

citations
Cited by 26 publications
(16 citation statements)
references
References 34 publications
0
16
0
Order By: Relevance
“…8,9,[15][16][17][18] Therefore, we assessed the transfection efficiency of pDNA into MDCK-I and MDCK-II cells using cationic liposomes (charge ratio at 1.0 : 2.3) under mechanical agitation. The expression levels of luciferase in both MDCK-I and MDCK-II cells were significantly high when the cells were agitated during transfection (Fig.…”
Section: Evaluation Of Cationic Liposome/pdna Complex Transport Acrosmentioning
confidence: 99%
See 1 more Smart Citation
“…8,9,[15][16][17][18] Therefore, we assessed the transfection efficiency of pDNA into MDCK-I and MDCK-II cells using cationic liposomes (charge ratio at 1.0 : 2.3) under mechanical agitation. The expression levels of luciferase in both MDCK-I and MDCK-II cells were significantly high when the cells were agitated during transfection (Fig.…”
Section: Evaluation Of Cationic Liposome/pdna Complex Transport Acrosmentioning
confidence: 99%
“…13) Therefore, it is very important to elucidate how a UWL affects the uptake and transport of cationic liposomes/pDNA complexes into epithelial cells in experiments performed in vitro. The characteristics or mechanisms of nanoparticle transport in epithelial cells have been reported, [14][15][16][17][18] whereas few reports have addressed the effect of UWLs.…”
mentioning
confidence: 99%
“…Preclinical experiments further demonstrated that alkylphospholipids, if used in liposomal form, are able to abolish multi drug resistance in human breast cancer xenografts (Zeisig et al, 2004) and inhibit metastasis if combined with an aggregation inhibitor inside liposomes in murine syngene (Wenzel et al, 2010) and human xenograft breast cancer models (Wenzel et al, 2009). Perifosine in combination with dioleylphosphoethanolamine, as a component of the liposome bilayer, also enhances transport of drugs across the blood brain barrier and in this way improves the treatment of intracerebral tumours and metastases (Orthmann et al, 2010). Miltefosine was also tested as an alternative approach for the treatment of patients with progressive cutaneous lesions from breast cancer in Phase I and II studies, which indicated that Miltefosine (either used alone or in conjunction with other therapies for distant metastases) is an effective and tolerable local treatment for cutaneous breast cancer (Clive et al, 1999;Unger & Eibl, 1991).…”
Section: Alkylphospholipids In Clinical Trialsmentioning
confidence: 99%
“…A positive correlation between membrane fluidity in the upper part of the membrane bilayer and transcytosis was found [6]. Similarly, it has been suggested that also polyunsaturated fatty acids influence transendothelial transport of cortisol across an MDCK barrier by inducing changes in membrane fluidity and somehow affecting tight junction integrity [13].…”
Section: Introductionmentioning
confidence: 99%
“…Increased transendothelial delivery was observed for liposomes containing both DOPE and perifosine as well as for liposomes containing only perifosine [6]. This suggests that either perifosine influences destabilization of endosomal memebranes to a much greater extent than DOPE or that endocytosis with destabilization of endosomal membrane might not be the primary mode of transendothelial delivery.…”
Section: Introductionmentioning
confidence: 99%